As filed with the Securities and Exchange Commission on September 14, 2021
Registration No. 333-226047
Registration No. 333-231746
Registration No. 333-237158
Registration No. 333-253696
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO:
FORM S-8 REGISTRATION STATEMENT NO. 333-226047
FORM S-8 REGISTRATION STATEMENT NO. 333-231746
FORM S-8 REGISTRATION STATEMENT NO. 333-237158
FORM S-8 REGISTRATION STATEMENT NO. 333-253696
UNDER
THE
SECURITIES ACT OF 1933
Translate Bio, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
61-1807780
|
(State or other jurisdiction
of incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
29 Hartwell Avenue
Lexington, Massachusetts
|
|
02421
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
2016 Stock Incentive Plan
2018 Equity Incentive Plan
2018 Employee Stock Purchase Plan
2021 Inducement Stock Incentive Plan
(Full titles of the plans)
Ronald C. Renaud Jr.
Chairperson and Chief Executive Officer
Translate Bio, Inc.
29
Hartwell Avenue
Lexington, Massachusetts, 02421
(617) 945-7361
(Name, address and telephone number of agent for service)
Copies to:
Krishna Veeraraghavan, Esq.
Oliver J. Board, Esq.
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, NY 10019-6064
(212) 373-3000
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer,
accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐